ATX 4.69% 6.1¢ amplia therapeutics limited

Ann: Promising Clinical Data 1b ACCENT Trial in Pancreatic Cancer, page-6

  1. 60 Posts.
    lightbulb Created with Sketch. 4
    Interesting results and hopefully the market sees the value at these levels, unless there is something they did not like or expected better ?

    I'm just looking at the Table they presented and all measures within the accent trial certainly show a better outcome,
    Considering phase 1B was not powered for efficacy surely makes the case more compelling.


 
watchlist Created with Sketch. Add ATX (ASX) to my watchlist
(20min delay)
Last
6.1¢
Change
-0.003(4.69%)
Mkt cap ! $16.67M
Open High Low Value Volume
6.4¢ 6.4¢ 6.1¢ $39.11K 630.8K

Buyers (Bids)

No. Vol. Price($)
3 39253 6.0¢
 

Sellers (Offers)

Price($) Vol. No.
6.4¢ 16657 1
View Market Depth
Last trade - 16.10pm 19/07/2024 (20 minute delay) ?
ATX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.